These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
568 related items for PubMed ID: 17065200
1. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Fang J, Zhou Q, Shi XL, Jiang BH. Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200 [Abstract] [Full Text] [Related]
2. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor. Sekine Y, Furuya Y, Nishii M, Koike H, Matsui H, Suzuki K. Biochem Biophys Res Commun; 2008 Jul 25; 372(2):356-61. PubMed ID: 18489904 [Abstract] [Full Text] [Related]
5. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma. Friedrichs N, Küchler J, Endl E, Koch A, Czerwitzki J, Wurst P, Metzger D, Schulte JH, Holst MI, Heukamp LC, Larsson O, Tanaka S, Kawai A, Wardelmann E, Buettner R, Pietsch T, Hartmann W. J Pathol; 2008 Dec 25; 216(4):428-39. PubMed ID: 18855347 [Abstract] [Full Text] [Related]
6. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH. Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094 [Abstract] [Full Text] [Related]
8. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways. Yang Y, Ikezoe T, Takeuchi T, Adachi Y, Ohtsuki Y, Koeffler HP, Taguchi H. Oncol Rep; 2006 Jun 05; 15(6):1581-90. PubMed ID: 16685399 [Abstract] [Full Text] [Related]
14. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Shen MR, Hsu YM, Hsu KF, Chen YF, Tang MJ, Chou CY. Carcinogenesis; 2006 May 05; 27(5):962-71. PubMed ID: 16400188 [Abstract] [Full Text] [Related]
15. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2. Nair PN, De Armond DT, Adamo ML, Strodel WE, Freeman JW. Oncogene; 2001 Dec 13; 20(57):8203-14. PubMed ID: 11781836 [Abstract] [Full Text] [Related]
16. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV. Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317 [Abstract] [Full Text] [Related]
17. Inhibition of epidermal growth factor receptor signaling by Saussurea involucrata, a rare traditional Chinese medicinal herb, in human hormone-resistant prostate cancer PC-3 cells. Way TD, Lee JC, Kuo DH, Fan LL, Huang CH, Lin HY, Shieh PC, Kuo PT, Liao CF, Liu H, Kao JY. J Agric Food Chem; 2010 Mar 24; 58(6):3356-65. PubMed ID: 20166659 [Abstract] [Full Text] [Related]
18. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN. Clin Cancer Res; 2006 Aug 01; 12(15):4755-65. PubMed ID: 16899627 [Abstract] [Full Text] [Related]
19. GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling. Choi JS, Paek AR, Kim SY, You HJ. Cancer Lett; 2010 Aug 28; 294(2):254-63. PubMed ID: 20206441 [Abstract] [Full Text] [Related]
20. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Kim JH, Xu C, Keum YS, Reddy B, Conney A, Kong AN. Carcinogenesis; 2006 Mar 28; 27(3):475-82. PubMed ID: 16299382 [Abstract] [Full Text] [Related] Page: [Next] [New Search]